Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 42

1.

The Global Cancer Genomics Consortium: interfacing genomics and cancer medicine.

Global Cancer Genomics Consortium.

Cancer Res. 2012 Aug 1;72(15):3720-4. Epub 2012 May 24.

2.

Future of clinical genomics in pediatric oncology.

Janeway KA, Place AE, Kieran MW, Harris MH.

J Clin Oncol. 2013 May 20;31(15):1893-903. doi: 10.1200/JCO.2012.46.8470. Epub 2013 Apr 15. Review.

PMID:
23589558
3.

Existing and emerging technologies for tumor genomic profiling.

MacConaill LE.

J Clin Oncol. 2013 May 20;31(15):1815-24. doi: 10.1200/JCO.2012.46.5948. Epub 2013 Apr 15. Review.

4.

Personalized Medicine in the Genomics Era: highlights from an international symposium on childhood heart disease.

Farra N, Manickaraj AK, Ellis J, Mital S.

Future Cardiol. 2012 Mar;8(2):157-60. doi: 10.2217/fca.12.3. Review.

5.

Genomics-driven oncology: framework for an emerging paradigm.

Garraway LA.

J Clin Oncol. 2013 May 20;31(15):1806-14. doi: 10.1200/JCO.2012.46.8934. Epub 2013 Apr 15. Review.

PMID:
23589557
6.

Functional genomics down under: RNAi screening in the Victorian Centre for Functional Genomics.

Thomas DW, Gould CM, Handoko Y, Simpson KJ.

Comb Chem High Throughput Screen. 2014 May;17(4):343-55. Review.

PMID:
24661211
7.

[The place of functional genomics in oncological research].

Bálint BL, Nagy L.

Magy Onkol. 2013 Mar;57(1):21-5. doi: MagyOnkol.2013.57.1.21. Epub 2013 Feb 10. Review. Hungarian.

8.

Using biointelligence to search the cancer genome: an epistemological perspective on knowledge recovery strategies to enable precision medical genomics.

Mousses S, Kiefer J, Von Hoff D, Trent J.

Oncogene. 2008 Dec;27 Suppl 2:S58-66. doi: 10.1038/onc.2009.354. Review.

PMID:
19956181
9.

Precision Oncology: The Road Ahead.

Senft D, Leiserson MDM, Ruppin E, Ronai ZA.

Trends Mol Med. 2017 Oct;23(10):874-898. doi: 10.1016/j.molmed.2017.08.003. Epub 2017 Sep 5. Review.

PMID:
28887051
10.

Translating genomic discoveries to the clinic in pediatric oncology.

Glade Bender J, Verma A, Schiffman JD.

Curr Opin Pediatr. 2015 Feb;27(1):34-43. doi: 10.1097/MOP.0000000000000172. Review.

PMID:
25502895
11.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
12.

Building a personalized medicine infrastructure at a major cancer center.

Meric-Bernstam F, Farhangfar C, Mendelsohn J, Mills GB.

J Clin Oncol. 2013 May 20;31(15):1849-57. doi: 10.1200/JCO.2012.45.3043. Epub 2013 Apr 15. Review.

13.

The clinical potential and challenges of sequencing cancer genomes for personalized medical genomics.

Cloonan N, Waddell N, Grimmond SM.

IDrugs. 2010 Nov;13(11):778-81. Review.

PMID:
21046525
14.

[The emergence and development of gene expression profiling: a key component of the 3B (bench, bedside, bytes) in translational research].

Cointet JP, Mogoutov A, Bourret P, El Abed R, Cambrosio A.

Med Sci (Paris). 2012 Mar;28 Spec No 1:7-13. doi: 10.1051/medsci/2012281s104. Epub 2012 Apr 9. Review. French.

15.

Promoting synergistic research and education in genomics and bioinformatics.

Yang JY, Yang MQ, Zhu MM, Arabnia HR, Deng Y.

BMC Genomics. 2008;9 Suppl 1:I1. doi: 10.1186/1471-2164-9-S1-I1. Review.

16.

[Genomics and clinical research for breast cancer].

Bertucci F, Birnbaum D.

Med Sci (Paris). 2012 Mar;28 Spec No 1:14-8. doi: 10.1051/medsci/2012281s105. Epub 2012 Apr 9. Review. French.

17.

The CCC National Partnership: an example of organizations collaborating on comprehensive cancer control.

Hohman K, Rochester P, Kean T, Belle-Isle L.

Cancer Causes Control. 2010 Dec;21(12):1979-85. doi: 10.1007/s10552-010-9644-0. Epub 2010 Sep 26. Review.

PMID:
20872239
18.

The global impact of the Gynecologic Cancer InterGroup in enhancing clinical trials in ovarian cancer.

Bacon M, Kitchener H, Stuart GC, Vermorken JB; Gynecologic Cancer InterGroup and participants of 4th Ovarian Cancer Consensus Conference.

Int J Gynecol Cancer. 2011 May;21(4):746-9. doi: 10.1097/IGC.0b013e31821bb446.

PMID:
21543935
19.

Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape.

Gajjar A, Bowers DC, Karajannis MA, Leary S, Witt H, Gottardo NG.

J Clin Oncol. 2015 Sep 20;33(27):2986-98. doi: 10.1200/JCO.2014.59.9217. Epub 2015 Aug 24. Review.

20.

Towards systematic functional characterization of cancer genomes.

Boehm JS, Hahn WC.

Nat Rev Genet. 2011 Jun 17;12(7):487-98. doi: 10.1038/nrg3013. Review.

PMID:
21681210

Supplemental Content

Support Center